**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1193-18-6 |2-Cyclohexen-1-One, 3-Methyl- | 98 | 214-769-7 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this
material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this
material have not been fully investigated.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Combustible liquid.
Vapors may be heavier than air. They can spread along the ground and
collect in low or confined areas. Containers may explode when heated.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use agent most
appropriate to extinguish fire. Use water spray, dry chemical,
carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Use a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Avoid contact
with eyes, skin, and clothing. Empty containers retain product
residue, (liquid and/or vapor), and can be dangerous. Keep container
tightly closed. Keep away from heat, sparks and flame. Avoid
ingestion and inhalation. Do not pressurize, cut, weld, braze,
solder, drill, grind, or expose empty containers to heat, sparks or
open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Keep container closed when not in use. Store in a tightly
closed container. Store in a cool, dry, well-ventilated area away
from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 1193-18-6:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear light amber
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 199.0 - 200.0 deg C @ 760.00m
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 68 deg C ( 154.40 deg F)
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .9710g/cm3
Molecular Formula: C7H10O
Molecular Weight: 110.16
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, carbon dioxide, calcium oxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1193-18-6: GW7340000
LD50/LC50:
CAS# 1193-18-6: Oral, mouse: LD50 = 1600 mg/kg.
Carcinogenicity:
2-Cyclohexen-1-One, 3-Methyl- -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 7/9 Keep container tightly closed and in a
well-ventilated place.
S 16 Keep away from sources of ignition - No
smoking.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 1193-18-6: No information available.
Canada
CAS# 1193-18-6 is listed on Canada's DSL List.
CAS# 1193-18-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1193-18-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 8/06/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
6-Amino-2-Naphthoic Acid, 90%
| 11668-47-4 |
|
Zirconium (IV) Oxide, P.A.
| 1314-23-4 |
|
cis-Dichlorodiamineplatinum(II), 99.99%
| 15663-27-1 |
|
1-Bromonaphthalene 96%, contains max. 2% 2-bromonaphthalene
| 90-11-9 |
|
1-Heptanesulfonic acid, sodium salt, monohydrate, HPLC grade
| 207300-90-1 |
|
1-Hexanesulfonic acid sodium salt, HPLC grade
| 2832-45-3 |
|
5-Bromo-1-pentene, 96%
| 1119-51-3 |
|
2,6-Diphenylphenol
| 2432-11-3 |
|
L-Cystine
| 56-89-3 |
|
1-Pentanesulfonic Acid, Sodium Salt Monohydrate, HPLC Grade
| 22767-49-3 |
|
1,1,2-Trichloroethane Density Standard
| 79-00-5 |
|
2-Ethoxyethanol, 99%
| 110-80-5 |
|
Antimony Trichloride
| 10025-91-9 |
|
2-Ethoxyethyl acetate 99%
| 111-15-9 |
|
DL-2-Octanol, 97%
| 123-96-6 |
|
2,2,2-Trifluoroethanol
| 75-89-8 |
|
5-Amino-2-methylindole, 98%
| 7570-49-2 |
|
Bromoacetaldehyde Diethyl Acetal, 97%
| 2032-35-1 |
|
2-Acetylcyclohexanone, 97%
| 874-23-7 |
|
Lauric acid, 98%
| 143-07-7 |
|
4-Methoxy-2-nitroaniline, 98%
| 96-96-8 |
|
1-Nitroso-2-naphthol-3,6-disulfonic acid disodium salt
| 0-00-0 |
|
Toluidine Blue O Zinc Chloride Double Salt
| 0-01-1 |
|
2,4,6-Triphenylpyrylium Chloride, 90%
| 40836-01-9 |
|
2-Isopropoxyethanol, 98%
| 109-59-1 |
|
2,6-Difluorobenzoyl Isocyanate
| 60731-73-9 |
|
1-(4-Chlorophenyl)-1-Cyclopropane- Carboxylic Acid, 99%
| 72934-37-3 |
|
1-Bromo-1-propene, mixture of isomers, 95%
| 590-14-7 |
|
3-Aminopyrrolidine Dihydrochloride
| 103831-11-4 |
|
2,2,4-Trimethylpentane, p.a.
| 540-84-1 |
|
Phenyl Salicylate, 99% (UV-Vis)
| 118-55-8 |
|
MOPS
| 1132-61-2 |
|
P-Naphtholbenzein, 90+% (UV-VIS)
| 145-50-6 |
|
1-Amino-4-Hydroxyanthraquinone, 96%
| 116-85-8 |
|
4-Aminoantipyrine, 98%
| 83-07-8 |
|
Sodium metatungstate, 2.82 density solution in water, stabilized
| 7732-18-5 |
|
8-Hydroxyquinoline, p.a.
| 148-24-3 |
|
3-Methyl-2-Cyclohexen-1-One, 98%
| 1193-18-6 |
|
Cerium(IV) sulfate tetrahydrate
| 10294-42-5 |
|
Sodium metatungstate hydrate, crystalline
| 12141-67-2 |
|
O-Methylbenzyl Cyanide, 98%
| 22364-68-7 |
|
l(-)-Glutathione, oxidized, hydrate, 95%
| 27025-41-8 |
|
Antimony Trioxide
| 1309-64-4 |
|
Dibutyl L-Tartrate
| 87-92-3 |
|
(-)-Terpinen-4-ol, 97%
| 562-74-3 |
|
3,5-Dinitrosalicylic Acid Monosodium Salt, Monohydrate, 97% (Titr.)
| 46506-88-1 |
|
4-Tert.-Butyl-Calix[4]arene-Crown-4-Complex
| 171058-95-0 |
|
4-Tert.-Butyl-Calix[4]Arene-Crown-5-Complex
| 99314-01-9 |
|
4-Tert.-Butyl-Calix[4]Arene-Crown-6-Complex
| 129518-51-0 |
|
2,3,4,5-Tetrafluoro-6-nitrobenzoic acid
| 16583-08-7 |
|
|